Hi Glen,
Thanks for your support.
We are in active partnering discussions and are pleased with how they are progressing.  There is interest in a number of our programs from multiple parties.  The most advanced programs, the SGLT inhibitor for diabetes and the skin lightener agents, are garnering the most interest.  We are receiving interest worldwide.
It's too difficult to predict when a deal will be finalized, but it is a high priority for us.
Would you be interested in being added to our email list?  If so, you would receive news releases and periodic updates as soon as they are released.

Thanks again for your support and if you have further questions, feel free to call me.
Kind regards,
Julie Jang
Director, Communications
Sirona Biochem Corp.